U.S. known cases of COVID are continuing to ease and now stand at their lowest level since early May, although the numbers need to be viewed gently, given the number Read more
Tag: Biotechnology
U.S. COVID cases continue to decline, as Minnesota nurses stage 3-day walkout over pay and understaffing
U.S. known cases of COVID are continuing to ease and now stand at their lowest level since early May, although the true tally is likely higher given how many people Read more
Omicron-targeting COVID boosters expected this week, but experts are worried there may be low uptake
The Food and Drug Administration is expected to authorize new COVID-19 booster shots this week that target the latest versions of the omicron variant but will do so without data Read more
Report finds Americans with long COVID losing billions in wages, as Moderna sues Pfizer and BioNTech over mRNA patents
Some 16 million Americans of working age have long-term COVID and as many as 4 million are not working as they struggle with their symptoms, according to a new report from Read more
Study finds Pfizer’s antiviral has little or even zero benefit for younger adults, and WHO says BA.5 omicron subvariant accounted for 74% of cases in latest week
Pfizer’s COVID antiviral Paxlovid appears to have little or no benefit for younger adults, although it still reduces the risk of hospitalization or death in seniors, according to a new Read more
Novartis to spin off, list Sandoz business
Novartis AG is planning to spin off its generics-and-biosimilars division Sandoz and list it as a standalone company in Switzerland, a move that will enable Novartis to focus on innovative Read more
Omicron-targeting COVID boosters may be out after Labor Day, and Moderna has joined Pfizer and BioNTech in filing for authorization
Americans age 12 and older could begin getting omicron-specific COVID-19 boosters soon after Labor Day, according to a new report. The New York Times reported Tuesday night that the Biden administration Read more
Omicron-specific boosters could be rolled out after Labor Day: report
Americans age 12 and older could begin getting omicron-specific COVID-19 boosters soon after Labor Day, according to a new report. The New York Times reported Tuesday night that the Biden Read more
Pfizer and BioNTech say data show COVID vaccine has more than 70% efficacy in small children, with cases now rising in just 7 states
Pfizer and German partner BioNTech on Tuesday offered updated COVID vaccine data supporting efficacy in children 6 months to 4 years old. The companies PFE, -2.07% BNTX, +0.07% said updated Read more
Large-scale study finds COVID patients at higher risk of brain fog and psychosis after two years compared with other respiratory illnesses
People who have had COVID-19 are facing a higher risk of neurological and psychiatric conditions some two years later as compared with other respiratory illnesses, according to a large-scale study Read more